Form 8-K - Current report:
SEC Accession No. 0001596783-24-000117
Filing Date
2024-11-05
Accepted
2024-11-05 07:10:45
Documents
15
Period of Report
2024-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctlt-20241105.htm   iXBRL 8-K 29446
2 EX-99.1 earningsreleaseex991-fy25x.htm EX-99.1 461850
6 image1.jpg GRAPHIC 45267
  Complete submission text file 0001596783-24-000117.txt   708982

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20241105.xsd EX-101.SCH 2090
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20241105_lab.xml EX-101.LAB 22392
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20241105_pre.xml EX-101.PRE 13095
17 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20241105_htm.xml XML 2707
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 241425605
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)